Coronary and peripheral stents are advanced vascular implants used to treat narrowed or obstructed arteries by restoring blood flow and providing structural support to the vessel walls. These devices are commonly deployed through minimally invasive catheter-based procedures, offering an effective alternative to more invasive surgical interventions

The Asia Pacific Coronary and Peripheral Stents Market is expected to experience substantial growth over the forecast period, expanding from US$ 1,871.0 million in 2024 to US$ 4,555.2 million by 2033, at a CAGR of 10.6% from 2025 to 2033. Market expansion is being driven by the increasing burden of cardiovascular diseases, ongoing improvements in healthcare infrastructure, and the growing preference for minimally invasive vascular interventions. Additionally, advancements in stent technologies, rising healthcare expenditures, and greater access to specialized cardiovascular care are further supporting market growth across the region.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 : https://www.businessmarketinsights.com/sample/BMIPUB00032771?utm_source=organic&utmmedium=1019 

Understanding Coronary and Peripheral Stents

Coronary and peripheral stents are small, expandable medical devices implanted into narrowed or blocked arteries to restore blood flow and prevent vessel collapse. Coronary stents are primarily used to treat coronary artery disease (CAD), while peripheral stents are designed for peripheral artery disease (PAD) affecting arteries outside the heart. Technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds have significantly improved treatment outcomes, reduced restenosis rates, and enhanced patient recovery.

Key Market Growth Drivers

Rising Prevalence of Cardiovascular Diseases

Cardiovascular diseases remain one of the leading causes of mortality across Asia Pacific. Rapid urbanization, sedentary lifestyles, unhealthy dietary habits, obesity, diabetes, and hypertension are increasing the incidence of coronary artery disease and peripheral artery disease. As a result, demand for effective interventional treatments such as stent implantation continues to rise.

Expansion of Healthcare Infrastructure

Countries such as China, India, South Korea, and Southeast Asian nations are making significant investments in healthcare infrastructure. New hospitals, specialized cardiac centers, and catheterization laboratories are increasing access to advanced cardiovascular procedures, thereby supporting market growth.

Growing Adoption of Minimally Invasive Procedures

Minimally invasive cardiovascular interventions offer benefits including shorter hospital stays, reduced complications, faster recovery times, and improved patient outcomes. These advantages are encouraging both physicians and patients to prefer stent-based procedures over traditional surgical approaches.

Technological Advancements in Stent Design

Continuous innovation in stent technology is enhancing treatment effectiveness. Drug-eluting stents dominate the market due to their superior ability to prevent restenosis, while bioresorbable vascular scaffolds and advanced peripheral stents are gaining attention for their potential to improve long-term vascular health.

Market Segmentation Analysis

By Product Type

The market is segmented into:

• Bare-Metal Stents
• Drug-Eluting Stents
• Bioresorbable Vascular Scaffolds
• Others

Drug-eluting stents held the largest market share in 2024 owing to their proven clinical efficacy, reduced risk of artery re-narrowing, and strong physician preference.

By Material Type

Based on material, the market includes:

• Metal
• Polymer
• Hybrid

The metal segment dominated the market in 2024 due to its durability, biocompatibility, cost-effectiveness, and extensive clinical validation.

By Application

Applications include:

• Coronary Artery Disease
• Peripheral Artery Disease

Coronary artery disease accounted for the largest market share, driven by its significantly higher prevalence and growing demand for interventional cardiology procedures.

By End User

End users comprise:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Labs
• Specialty Clinics

Hospitals remained the leading end-user segment due to advanced infrastructure, specialized cardiac care facilities, and the ability to manage complex cardiovascular cases.

China Leads the Regional Market

China continues to dominate the Asia Pacific coronary and peripheral stents market and is expected to remain the fastest-growing country throughout the forecast period. The country's leadership is supported by:

• Large patient population
• Government-backed healthcare reforms
• Expanding hospital infrastructure
• Strong domestic manufacturing capabilities
• Growing adoption of advanced stent technologies

Major domestic manufacturers such as Lepu Medical and MicroPort are competing alongside international companies, creating a highly competitive market environment that promotes innovation and affordability.

Emerging Opportunities Across Asia Pacific

Beyond China, countries including India, Indonesia, Vietnam, Thailand, Malaysia, and the Philippines are experiencing growing demand for cardiovascular interventions. Rising healthcare spending, increasing awareness of cardiovascular health, and improved access to advanced medical technologies are creating substantial growth opportunities for market participants.

Additionally, physician training programs, collaborations between healthcare providers and medical device companies, and supportive government initiatives are expected to further accelerate stent adoption across the region.

Competitive Landscape

Key companies operating in the Asia Pacific coronary and peripheral stents market include:

• Medtronic
• Boston Scientific Corporation
• Abbott
• B. Braun SE
• TERUMO CORPORATION
• Teleflex Incorporated
• Lepu Medical Technology (Beijing) Co. Ltd.
• Cook Medical
• Meril Life Sciences
• Translumina

These companies continue to focus on product innovation, strategic partnerships, geographical expansion, and mergers and acquisitions to strengthen their market positions and address evolving clinical needs.

Future Outlook

The Asia Pacific coronary and peripheral stents market is expected to maintain strong growth over the next decade. Increasing cardiovascular disease burden, healthcare modernization initiatives, expanding access to advanced treatment options, and continuous technological innovation will remain key growth drivers. As healthcare systems continue to evolve across both developed and emerging economies, the region is set to become a major global hub for cardiovascular intervention technologies.

About Us

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.